BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

SG Americas Securities, LLC's Holding History (CIK: 0001313360)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 10,220 Value ($000) $1 Avg Close Range
Q3 2025
Shares 10,220 Value ($000) $1 Avg Close Range
Q2 2025
Shares 16,220 Value ($000) $2 Avg Close Range
Q1 2025
Shares 21,020 Value ($000) $2 Avg Close Range
Q4 2024
Shares 14,620 Value ($000) $1 Avg Close Range
Q3 2024
Shares 22,000 Value ($000) $2 Avg Close Range
Q2 2024
Shares 22,000 Value ($000) $2 Avg Close Range
Q1 2024
Shares 27,000 Value ($000) $2 Avg Close Range
Q4 2023
Shares 22,000 Value ($000) $2 Avg Close Range
Q3 2023
Shares 22,000 Value ($000) $2 Avg Close Range
Q2 2023
Shares 22,000 Value ($000) $1 Avg Close Range
Q1 2023
Shares 22,000 Value ($000) $1 Avg Close Range